JPH04501207A - Dna領域における長さ多型を分析する方法 - Google Patents
Dna領域における長さ多型を分析する方法Info
- Publication number
- JPH04501207A JPH04501207A JP1511152A JP51115289A JPH04501207A JP H04501207 A JPH04501207 A JP H04501207A JP 1511152 A JP1511152 A JP 1511152A JP 51115289 A JP51115289 A JP 51115289A JP H04501207 A JPH04501207 A JP H04501207A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- primer
- sequence
- sequences
- method described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 55
- 108020004414 DNA Proteins 0.000 claims description 38
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 15
- 108091034117 Oligonucleotide Proteins 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 11
- 230000000295 complement effect Effects 0.000 claims description 9
- 230000010076 replication Effects 0.000 claims description 8
- 238000000137 annealing Methods 0.000 claims description 7
- 239000007795 chemical reaction product Substances 0.000 claims description 7
- 238000004925 denaturation Methods 0.000 claims description 6
- 230000036425 denaturation Effects 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 239000007850 fluorescent dye Substances 0.000 claims description 3
- 230000002068 genetic effect Effects 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 238000005194 fractionation Methods 0.000 claims 1
- 230000003278 mimic effect Effects 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 description 19
- 239000000499 gel Substances 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 102000054765 polymorphisms of proteins Human genes 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000008774 maternal effect Effects 0.000 description 4
- 230000008775 paternal effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 241000255601 Drosophila melanogaster Species 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000090512 Aphyosemion melanogaster Species 0.000 description 1
- 101100459439 Caenorhabditis elegans nac-2 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000255348 Drosophila sp. (in: Insecta) Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241001524679 Escherichia virus M13 Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- 108091092919 Minisatellite Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000008297 genomic mechanism Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000003793 prenatal diagnosis Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (11)
- 1.(a)分析しょうとするDNAと少なくとも1つのプライマー対とのアニー リング〔ここに、プライマー対の分子の一方は単純なまたは潜伏的に単純なDN A配列における5′または3′のフランキングの相補鎖の1つと実質的に相補的 であり、アニーリングは、該プライマーの一方とのプライマー一制御複製反応に よって得られる合成産物が変性後に他方のプライマーをアニーリングするための 鋳型として利用できるような方向で起こるものである]、(b)プライマー制御 したPCR反応、および(c)PCR反応の反応産物の分離および分折からなる ことを特徴とする、DNA領域の長さ多型を分抗するための方法。
- 2.単純なまたは潜伏的に単純なDNA配列が実質的にトリヌクレオチドのモチ ーフから構成されている請求項1に記載の方法。
- 3.単純なまたは潜伏的に単純なDNA配列がCAG/CTGの配列モチーフを 含有している請求項1または2に記載の方法。
- 4.プライマー対の分子を、50から500ヌクレオチド離れて、分析しょうと するDNAとアニーリングする請求項1から請求項3までのいずれかに記載の方 法。
- 5.少なくとも2つのプライマー対を使用する請求項1から請求項4までのいず れかに記載の方法。
- 6.2から50個のプライマー対を使用する請求項1から請求項4までのいずれ かに記載の方法。
- 7.プライマーが15から25ヌクレオチドの長さを有する請求項1から請求項 6までのいずれかに記載の方法。
- 8.プライマー対の特定のPCR反応産物が適当なゲルにおいて個々のバンドに 分離することができるようにプライマー対の位置を選択する請求項1から請求項 7までのいずれかに記載の方法。
- 9.特定のPCR反応産物を放射活性標識または蛍光性色素剤などの非一放射活 性標識によって検出する請求項1から請求項8までのいずれかに記載の方法。
- 10.分析しようとする単純なまたは潜伏的に単純なDNA配列を、遺伝学的規 定された遺伝子座内、またはその隣に配置させて、見いだされる多型がその遺伝 子座のマーカーとして利用できるようにする請求項1から請求項9までのいずれ かに記載の方法。
- 11.(a)単純なまたは潜伏的に単純なDNA配列をフランキングする、放射 活性または蛍光的に標識されていてもよい1から50個のオリゴヌクレオチドプ ライマー対の等モル混合物を含有する1つまたは幾つかの管、 (b)複製のための酵素を含有する管、(c)4つのデオキシヌクレオシド3リ ン酸を含有する管、(d)適当な緩衝化保存溶液を含有する管、および要すれば (e)キットの成分を試験するために適した対照DNAを含有する管、 からなる請求項1から請求項10までのいずれかに記載の方法を実施するための キット。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3834636A DE3834636A1 (de) | 1988-10-11 | 1988-10-11 | Verfahren zur analyse von laengenpolymorphismen in dna-bereichen |
| DE3834636.2 | 1988-10-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04501207A true JPH04501207A (ja) | 1992-03-05 |
| JP3218318B2 JP3218318B2 (ja) | 2001-10-15 |
Family
ID=6364896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51115289A Expired - Lifetime JP3218318B2 (ja) | 1988-10-11 | 1989-10-11 | Dna領域における長さ多型を分析する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | USRE37984E1 (ja) |
| EP (1) | EP0438512B2 (ja) |
| JP (1) | JP3218318B2 (ja) |
| AT (1) | ATE161585T1 (ja) |
| DE (2) | DE3834636A1 (ja) |
| HK (1) | HK1004341A1 (ja) |
| WO (1) | WO1990004040A1 (ja) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9002259A (nl) * | 1990-10-17 | 1992-05-18 | Eurodiagnostics B V | Werkwijze voor het bepalen van een genotype door het vergelijken van de nucleotidensequentie van leden van een genfamilie, alsmede kit voor het opsporen van genetische variaties. |
| US5364759B2 (en) * | 1991-01-31 | 1999-07-20 | Baylor College Medicine | Dna typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats |
| WO1992013968A1 (en) * | 1991-02-07 | 1992-08-20 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Monolocus-specific hypervariable probes |
| US6207373B1 (en) | 1998-02-25 | 2001-03-27 | Nanogen, Inc. | Methods for determining nature of repeat units in DNA |
| US7008771B1 (en) | 1994-09-30 | 2006-03-07 | Promega Corporation | Multiplex amplification of short tandem repeat loci |
| WO1996017082A2 (en) * | 1994-11-28 | 1996-06-06 | E.I. Du Pont De Nemours And Company | Compound microsatellite primers for the detection of genetic polymorphisms |
| EP1007730A4 (en) | 1996-08-30 | 2004-04-28 | Invitrogen Corp | METHODS OF IDENTIFYING AND ISOLATING SPECIFIC NUCLEOTIDE SEQUENCES IN cDNA AND GENOMIC DNA |
| US6306588B1 (en) | 1997-02-07 | 2001-10-23 | Invitrogen Corporation | Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof |
| GB9713597D0 (en) * | 1997-06-28 | 1997-09-03 | Sec Dep Of The Home Department | Improvements in and relating to forensic identification |
| US6238863B1 (en) | 1998-02-04 | 2001-05-29 | Promega Corporation | Materials and methods for indentifying and analyzing intermediate tandem repeat DNA markers |
| CA2489208C (en) | 2003-02-24 | 2012-11-06 | Morinaga Milk Industry Co., Ltd. | Interleukin-6 suppressive agent |
| CN1787829B (zh) | 2003-03-14 | 2010-06-16 | 明治乳业株式会社 | 抗轮状病毒感染的组合物及制备该组合物的方法 |
| AU2003225410A1 (en) | 2003-03-21 | 2004-10-11 | Academisch Ziekenhuis Leiden | Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| US20050112591A1 (en) * | 2003-11-25 | 2005-05-26 | Applera Corporation | Novel method for isolating single stranded product |
| WO2007123391A1 (en) | 2006-04-20 | 2007-11-01 | Academisch Ziekenhuis Leiden | Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene. |
| EP1857548A1 (en) | 2006-05-19 | 2007-11-21 | Academisch Ziekenhuis Leiden | Means and method for inducing exon-skipping |
| SI2049664T1 (sl) | 2006-08-11 | 2012-04-30 | Prosensa Technologies Bv | Enojna veriga oligonukleotidov, komplementarna repetitivnim elementom, za zdravljenje genetskih bolezni, povezanih z nestabilnostjo dnk ponovitev |
| CA2693742A1 (en) | 2007-07-12 | 2009-01-15 | Prosensa Technologies B.V. | Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| WO2009008727A2 (en) | 2007-07-12 | 2009-01-15 | Prosensa Technologies B.V. | Molecules for targeting compounds to various selected organs or tissues |
| ES2639852T3 (es) | 2007-10-26 | 2017-10-30 | Academisch Ziekenhuis Leiden | Medios y métodos para contrarrestar los trastornos musculares |
| USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
| WO2009099326A1 (en) | 2008-02-08 | 2009-08-13 | Prosensa Holding Bv | Methods and means for treating dna repeat instability associated genetic disorders |
| EP2119783A1 (en) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means |
| EP2421971B1 (en) | 2009-04-24 | 2016-07-06 | BioMarin Technologies B.V. | Oligonucleotide comprising an inosine for treating dmd |
| WO2011078672A1 (en) | 2009-12-24 | 2011-06-30 | Prosensa Technologies B.V. | Molecule for treating an inflammatory disorder |
| NZ627896A (en) | 2012-01-27 | 2016-11-25 | Biomarin Technologies B V | Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy |
| GB201418980D0 (en) | 2014-10-24 | 2014-12-10 | Univ Portsmouth | Cell assay kit and method |
| US10822647B2 (en) | 2016-07-12 | 2020-11-03 | Biodynamics S.R.L. | Methods for using long ssDNA polynucleotides as primers (superprimers) in PCR assays |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS1355B6 (is) | 1984-11-12 | 1989-04-19 | Lister Institute Of Preventive Medicine | Fjölkjarna kannar |
| EP0342717A3 (en) | 1984-11-12 | 1990-04-25 | THE LISTER INSTITUTE OF PREVENTIVE MEDICINE Royal National Orthopaedic Hospital | Polynucleotide probes |
| ES8706823A1 (es) * | 1985-03-28 | 1987-06-16 | Cetus Corp | Un procedimiento para detectar la presencia o ausencia de al menos una secuencia especifica de acidos nucleicos en una muestra |
| CA1284931C (en) * | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
| US4987066A (en) | 1986-11-07 | 1991-01-22 | Max Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Process for the detection of restriction fragment length polymorphisms in eukaryotic genomes |
| EP0402400B1 (en) | 1988-02-18 | 1999-09-08 | University of Utah | Genetic identification employing dna probes of variable number tandem repeat loci |
| US5075217A (en) | 1989-04-21 | 1991-12-24 | Marshfield Clinic | Length polymorphisms in (dC-dA)n ·(dG-dT)n sequences |
| US5364759B2 (en) | 1991-01-31 | 1999-07-20 | Baylor College Medicine | Dna typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats |
-
1988
- 1988-10-11 DE DE3834636A patent/DE3834636A1/de active Granted
-
1989
- 1989-10-11 EP EP89912096A patent/EP0438512B2/de not_active Expired - Lifetime
- 1989-10-11 DE DE58909827T patent/DE58909827D1/de not_active Expired - Lifetime
- 1989-10-11 JP JP51115289A patent/JP3218318B2/ja not_active Expired - Lifetime
- 1989-10-11 WO PCT/EP1989/001203 patent/WO1990004040A1/de not_active Ceased
- 1989-10-11 HK HK98103477A patent/HK1004341A1/xx not_active IP Right Cessation
- 1989-10-11 AT AT89912096T patent/ATE161585T1/de not_active IP Right Cessation
-
2000
- 2000-06-09 US US09/591,383 patent/USRE37984E1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0438512B2 (de) | 2005-07-27 |
| JP3218318B2 (ja) | 2001-10-15 |
| USRE37984E1 (en) | 2003-02-11 |
| DE3834636C2 (ja) | 1992-02-20 |
| DE58909827D1 (de) | 1998-02-05 |
| WO1990004040A1 (de) | 1990-04-19 |
| EP0438512B1 (de) | 1997-12-29 |
| HK1004341A1 (en) | 1998-11-20 |
| DE3834636A1 (de) | 1990-04-19 |
| ATE161585T1 (de) | 1998-01-15 |
| EP0438512A1 (de) | 1991-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH04501207A (ja) | Dna領域における長さ多型を分析する方法 | |
| US5766847A (en) | Process for analyzing length polymorphisms in DNA regions | |
| JP3175110B2 (ja) | リガーゼ/ポリメラーゼ媒体された単一ヌクレオチド多型のジェネティックビットアナリシスおよび遺伝子解析におけるその使用 | |
| US6045994A (en) | Selective restriction fragment amplification: fingerprinting | |
| Dodgson et al. | DNA marker technology: a revolution in animal genetics | |
| HK1004341B (en) | Process for analysing length polymorphisms in dna domains | |
| Plotsky et al. | Genetic characterization of highly inbred chicken lines by two DNA methods: DNA fingerprinting and polymerase chain reaction using arbitrary primers | |
| EP1693469A2 (en) | Detecting DNA sequence variations | |
| KR20050046330A (ko) | 유전자 감식에 의한 소고기의 원산지 추적 및 개체식별 방법 | |
| Lamont et al. | Genetic markers linked to quantitative traits in poultry | |
| US6821734B2 (en) | Method for testing nucleic acid sequence | |
| JPH04506456A (ja) | 突然変異のスペクトルの決定 | |
| KR101777161B1 (ko) | 개의 고관절이형성증을 예측 또는 진단하기 위한 멀티플렉스 단일염기다형성 마커 조성물 및 이를 이용한 예측 또는 진단 방법 | |
| US10344323B1 (en) | CPG sites differentially methylated in smokers and non-smokers | |
| US6403303B1 (en) | Method and reagents for testing for mutations in the BRCA1 gene | |
| US7217516B2 (en) | Methods and kits comprising AFLP primers, and ramp primers with a part complementary to a compound microsatellite repeat and an anchor part complementary to nucleotides adjacent to the repeat | |
| Lockley et al. | Intron variability in an actin gene can be used to discriminate between chicken and turkey DNA | |
| Ransom et al. | Mapping zebrafish mutations by AFLP | |
| GB2206586A (en) | Polynucleotide probes | |
| TWI686482B (zh) | 隨機引子組及使用其之dna基因庫的製作方法 | |
| JP4097288B2 (ja) | ホップにおける遺伝学的品種識別方法 | |
| JP2009005698A (ja) | イヌ科動物の遺伝子型決定のためのマイクロサテライト配列 | |
| US20120064528A1 (en) | Methods and reagents for quantifying nucleic acid fragmentation and apoptosis (qlm-pcr, cell number qpcr and apoqpcr) | |
| EP1250449B1 (en) | Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals | |
| KR20100069670A (ko) | 암 검출에 사용하기 위한 3.4 케이비 미토콘드리아 디엔에이 결실 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080810 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080810 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090810 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 9 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 9 |